Initially, Kulke et al. [42] in 2009 reported that 51% of pancreatic NETs exhibited a loss of MGMT expression, whereas all pulmonary carcinoid tumor patients (n = 40) demonstrated positive MGMT expression. Here, MGMT is linked to pancreatic neuroendocrine tumor.